Global Health Innovation Act of 2017
USA115th CongressHR-1660| House
| Updated: 1/3/2019
Albio Sires
Democratic Representative
New Jersey
Cosponsors (19)
Daniel M. Donovan (Republican)Joyce Beatty (Democratic)David N. Cicilline (Democratic)Eliot L. Engel (Democratic)John J. Faso (Republican)Suzan K. DelBene (Democratic)Carlos Curbelo (Republican)Ted Lieu (Democratic)Mario Diaz-Balart (Republican)Christopher H. Smith (Republican)Timothy J. Walz (Democratic)Ryan A. Costello (Republican)David G. Reichert (Republican)Brad Sherman (Democratic)Nydia M. Velázquez (Democratic)William R. Keating (Democratic)Ileana Ros-Lehtinen (Republican)Zoe Lofgren (Democratic)Gerald E. Connolly (Democratic)
Foreign Affairs Committee, Foreign Relations Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Global Health Innovation Act of 2017 This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities. Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Foreign Affairs.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Mr. Royce (CA) moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H439-440)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H538-539)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Foreign Relations.
Committee on Foreign Relations. Ordered to be reported without amendment favorably.
Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)
Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 115-411.
International Affairs
Child healthCongressional oversightDrug therapyForeign aid and international reliefHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methodsProduct development and innovationPublic-private cooperationU.S. Agency for International Development (USAID)Women's healthWorld health
Global Health Innovation Act of 2017
USA115th CongressHR-1660| House
| Updated: 1/3/2019
Global Health Innovation Act of 2017 This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities. Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Foreign Affairs.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Mr. Royce (CA) moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H439-440)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H538-539)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Foreign Relations.
Committee on Foreign Relations. Ordered to be reported without amendment favorably.
Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)
Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 115-411.
Albio Sires
Democratic Representative
New Jersey
Cosponsors (19)
Daniel M. Donovan (Republican)Joyce Beatty (Democratic)David N. Cicilline (Democratic)Eliot L. Engel (Democratic)John J. Faso (Republican)Suzan K. DelBene (Democratic)Carlos Curbelo (Republican)Ted Lieu (Democratic)Mario Diaz-Balart (Republican)Christopher H. Smith (Republican)Timothy J. Walz (Democratic)Ryan A. Costello (Republican)David G. Reichert (Republican)Brad Sherman (Democratic)Nydia M. Velázquez (Democratic)William R. Keating (Democratic)Ileana Ros-Lehtinen (Republican)Zoe Lofgren (Democratic)Gerald E. Connolly (Democratic)
Foreign Affairs Committee, Foreign Relations Committee
International Affairs
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Child healthCongressional oversightDrug therapyForeign aid and international reliefHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methodsProduct development and innovationPublic-private cooperationU.S. Agency for International Development (USAID)Women's healthWorld health